Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer
Nicholas Spetsieris, Myrto Boukovala, Ioannis Alafis, et al.
BJU International
|
July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer
Spyridon P Basourakos, John W Davis, Brian F Chapin, et al.
European Urology Oncology
|
July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis
Amado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.
Urologic Oncology
|
January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomy
Justin R Gregg, Resa Magill, Andrew M Fang, et al.
Translational Behavioral Medicine
|
June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients
Rebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Urology
|
May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials
Andrew Fang, Daniel E Frigo, Andrew Hahn, et al.
The Journal of Urology
|
February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study
Tarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Science Translational Medicine
|
April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Sumit K Subudhi, Luis Vence, Hao Zhao, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer
Nicholas Spetsieris, Myrto Boukovala, Ioannis Alafis, et al.
BJU International
|
July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer
Spyridon P Basourakos, John W Davis, Brian F Chapin, et al.
European Urology Oncology
|
July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis
Amado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.
Urologic Oncology
|
January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomy
Justin R Gregg, Resa Magill, Andrew M Fang, et al.
Translational Behavioral Medicine
|
June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients
Rebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Urology
|
May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials
Andrew Fang, Daniel E Frigo, Andrew Hahn, et al.
The Journal of Urology
|
February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study
Tarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Science Translational Medicine
|
April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Sumit K Subudhi, Luis Vence, Hao Zhao, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
Page
of 12